Search results
Blood cancer multiple myeloma, once a death sentence, is now highly treatable. Here's why
USA TODAY via Yahoo News· 9 months agoAfter Judith Harding was diagnosed with multiple myeloma in 2009, she decided to retire, sold her...
How Triple-Refractory Multiple Myeloma Is Treated
Verywell Health via Yahoo News· 2 years agoTriple refractory multiple myeloma usually requires the use of two or more different kinds of drugs to improve survival outcomes and quality of life....
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
Zacks via Yahoo Finance· 3 months agoJohnson & Johnson JNJ announced that an FDA committee has unanimously recommended expanded use of...
Bristol Myers' Revlimid Takes A 32% Hit As Generics Keep Coming
Investor's Business Daily· 1 year agoBristol Myers Squibb's Revlimid took fewer than expected generic hits in the fourth quarter,...
Legend (LEGN) Up 4% on sNDA Submission for Carvykti Expanded Use
Zacks via Yahoo Finance· 12 months agoLegend (LEGN) announces regulatory submission for expanded use of Carvykti to include adult patients...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 1 week agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
Bristol Myers (BMY), TSVT Application for Abecma Accepted
Zacks via Yahoo Finance· 1 year agoBristol Myers Squibb BMY and partner 2seventy bio, Inc. TSVT announced that the FDA has accepted the...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Abecma
Zacks via Yahoo Finance· 2 months agoBristol Myers (BMY) wins FDA approval for CAR T cell immunotherapy, Abecma, in earlier lines of...
J&J secures EMA backing for earlier CAR-T use in multiple myeloma
BioPharma Dive via Yahoo Finance· 3 months agoEuropean drug regulators recommended clearing J&J and Legend Biotech's Carvykti for use as early as...
FDA approves CAR-T therapies from J&J, Bristol Myers for earlier myeloma use
BioPharma Dive via Yahoo Finance· 2 months agoThe FDA quickly followed last week’s clearance of Bristol Myers’ Abecma with an OK for J&J’s...